Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hospital@Home: improving discharge management and reducing the risk of rehospitalizations in multimorbid Patients - Protocol for a randomized clinical trial.

Trials·2026

Same author

Coffee Consumption Correlates With Better Cognitive Performance in Patients With a High Incidence for Stroke.

Journal of the American Heart Association·2024

Same author

A Symptom-Checker for Adult Patients Visiting an Interdisciplinary Emergency Care Center and the Safety of Patient Self-Triage: Real-Life Prospective Evaluation.

Journal of medical Internet research·2024

Same author

Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation.

Nutrients·2024

Same author

Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey.

BMJ open diabetes research & care·2023

Same author

Diagnosis and Treatment of Hereditary Central Diabetes Insipidus in a Swiss Family With a Mutation in the <i>AVP</i> Gene.

JCEM case reports·2023

Search research articles

Related Experiment Video

Updated: May 27, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins in clinical medicine.

Jonas Rutishauser¹

¹Clinic for Internal Medicine, Hospital Center, Biel-Bienne, Switzerland.

Swiss Medical Weekly

|November 22, 2011

Summary

Statins effectively lower LDL cholesterol, reducing vascular events and coronary mortality. Patient-specific risk assessment is crucial for primary prevention, balancing benefits against potential side effects like increased diabetes risk.

Area of Science:

Cardiology
Pharmacology
Preventive Medicine

Background:

Statins inhibit cholesterol biosynthesis, primarily reducing low-density lipoprotein (LDL) cholesterol.
This reduction correlates with a significant decrease in major vascular events and coronary mortality.
The cost-effectiveness of statins for primary prevention is debated, necessitating individualized risk assessment.

Purpose of the Study:

To review the efficacy and safety of statin therapy in cardiovascular disease prevention.
To discuss the role of statins in primary versus secondary prevention, particularly in patients with diabetes.
To evaluate the benefits and risks of statin therapy, including pleiotropic effects and potential side effects.

Main Methods:

Review of randomized controlled trials and meta-analyses on statin therapy.

Related Experiment Videos

Last Updated: May 27, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Analysis of LDL cholesterol reduction and its impact on vascular events.

Consideration of patient-specific factors, cardiovascular risk calculators, and guidelines for statin use.

Main Results:

Statins achieve approximately a 20% relative reduction in vascular events per mmol/L LDL reduction.
Statin therapy is generally indicated for patients with diabetes due to their high cardiovascular risk.
Statins are well-tolerated and safe when appropriate precautions are taken; ezetimibe can be added if needed.
The vascular benefits of statins outweigh the small risk of incident diabetes mellitus.

Conclusions:

Statin therapy is a cornerstone in cardiovascular risk reduction, with benefits extending beyond LDL cholesterol lowering.
Individualized treatment strategies, considering patient risk and tolerance, are essential for optimal statin use.
While statins have pleiotropic effects, their primary benefit stems from LDL cholesterol reduction.